Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Pharmaceutica Sinica ; (12): 1291-1300, 2011.
Artigo em Chinês | WPRIM | ID: wpr-232995

RESUMO

Fructose-1, 6-bisphosphatase (FBPase), a rate-limiting enzyme involved in the pathway of gluconeogenesis, can catalyze the hydrolysis of fructose-1, 6-bisphosphate to fructose-6-phosphate. Upon inhibiting the activity of FBPase, the production of endogenous glucose can be decreased and the level of blood glucose lowered. Therefore, inhibitors of FBPase are expected to be novel potential therapeutics for the treatment of type II diabetes. Recent research efforts were reviewed in the field of developing allosteric inhibitors interacting with the AMP binding site of FBPase.


Assuntos
Animais , Humanos , Monofosfato de Adenosina , Química , Sítio Alostérico , Sítios de Ligação , Glicemia , Metabolismo , Diabetes Mellitus Tipo 2 , Sangue , Inibidores Enzimáticos , Química , Farmacologia , Frutose-Bifosfatase , Química , Metabolismo , Frutosedifosfatos , Metabolismo , Frutosefosfatos , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA